EDRH
INDP icon

Edmond de Rothschild Holding’s Indaptus Therapeutics INDP Stock Holding History

Edmond de Rothschild Holding’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Hold
0
– -$3K – 587
2019
Q2 		– Hold
0
– – – 572
2019
Q1 		– Hold
0
– – – 601
2018
Q4 		– Sell
-36
Closed -$491K – 649
2018
Q3 		$455K Hold
36
– – 0.01% 347
2018
Q2 		$343K Buy
36
+1
+3% +$11.1K 0.01% 377
2018
Q1 		$489K Buy
35
+7
+25% +$99.2K 0.01% 353
2017
Q4 		$329K Buy
+28
New +$434K 0.01% 425

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Edmond de Rothschild Holding's INDP Position: Q3 2019 in Review

Edmond de Rothschild Holding held its Indaptus Therapeutics (INDP) position steady in Q3 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Edmond de Rothschild Holding first reported a position in INDP in Q4 2017 and has held it in 4 quarters since. The position peaked at $489K in Q1 2018. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

  • Edmond de Rothschild Holding held 0 shares of Indaptus Therapeutics worth $0 as of Q3 2019.
  • Edmond de Rothschild Holding left its Indaptus Therapeutics share count unchanged in Q3 2019.
  • Indaptus Therapeutics made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q3 2019, its #587 holding.
  • Edmond de Rothschild Holding first reported a position in Indaptus Therapeutics in Q4 2017 and has held it in 4 quarters since.
  • Edmond de Rothschild Holding's Indaptus Therapeutics position peaked at $489K in Q1 2018.
  • 33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2019, filed 14 Nov 2019.